Bacteriocinogenicity and production of pyocins from Pseudomonas species isolated in Lagos, Nigeria

African Journal of Biotechnology

Volumn 5, Issue 11, 2006, Pages 1072-1077

  Iwalokun, B A ^a   Akinsinde, K A ^b   Lanlenhin, O ^a   Onubogu, C C ^b  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

Antibacterial activity; Nigeria; Pseudomonas species; Pyocins

Indexed keywords

PYOCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURN; CONTROLLED STUDY; DIARRHEA; EYE INFECTION; KLEBSIELLA; LISTERIA MONOCYTOGENES; NIGERIA; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PUTIDA; PSEUDOMONAS STUTZERI; SKIN INFECTION; SPECIES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRAVIOLET RADIATION; URINARY TRACT INFECTION; WOUND;

BACILLUS CEREUS; KLEBSIELLA; LISTERIA MONOCYTOGENES; NEGIBACTERIA; POSIBACTERIA; PROTEUS FLUORESCENS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PUTIDA; PSEUDOMONAS STUTZERI; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VIBRIO PARAHAEMOLYTICUS;

EID: 33745032368     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Akinyemi KO, Olukoya DK, Oyefolu AO, Amorighoye EP, Omonigbehin EO (2000). Prevalence of multiple drug resistance Salmonella typhi among clinically diagnosed typhoid fever patients in Lagos, Nigeria. Z. Naturforsch. 55: 489 - 493.
2. Atoyeba OA, Sowemimo GOA, Odugbemi T (1982). Bacterial flora of burns wounds in Lagos, Nigeria. Nig. Med. J. 12 : 125 - 179.
3. Bett R, Murray K, MacPhee S (1993). Evaluation of fluorocult LMX broth for the simultaneous detection of total coli forms and Esherichia coli. Campden Food and Drink Research Association. Technical Memorandum. p. 705.
4. Braun V, Pilsl H, Gross PC (1994). structures, mode of action, transfer through membranes and evolution. Arch. Microbiol. 161: 170 - 177.
5. th Ann Mtng. Amer. Soc. Microbiol. p. 419.
6. Duport C, Baycee C, Michel-Briand Y (1995). Molecular characterization of pyocin S3, a novel s-type pyocin from Pseudomonas aeruginosa. J Biol Chem. 270: 8920 - 8927.
7. Egri-Okwaji MTC, Iroha EO, Kesah CN, Odugbemi T (1988). Bacterial pathogens causing Neonatal sepsis in an out-born Neonatal unit in Lagos, Nigeria. Nig Med. J. 18: 349 - 351.
8. Hassan HM, Fridovitch I (1980). Mechanism of the antibiotic action of pyocyanine. J Bacteriol. 141: 156 - 163.
9. Iwalokun BA, Gbenle GO, Smith SI, Ogunledun A, Akinsinde KA, Omonigbehin EA (2001). Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance. J. Health Popul Nutr. 19: 183-190.
10. Keisuke N, Kayoko T, Hiroshi,I, Tomoyuki S, Makoto K, Shigeyiko K, Makoto O, Takahiro M, Hirotada M, Tetsuya H (2001). The R -type pyocin of Pseudomonas aeruginosa is related to P2 phage, and F-type is related to lambda phage. Molecular Microbiol. 38: 213 - 231
11. Klinger JD, Straus DC, Hilton CE, Bass JA (1978). Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: demonstration by radioimmunoassay. J Infect. Dis. 138: 49 - 58.
12. Matsui H, Sano Y, Ishibara H, Shinomiya T (1993). Regulation of pyocin genes in Pseudomonas aeruginosa by positive (Prt N) and negative (Prt R) regulatory genes. J. Bacteriol. 175: 1257-1263.
13. Olukoya DK, Asielue JO, Olasupo NA, Ikea JK (1995). Plasmid profiles and antibiotic susceptibility patterns of Staphylococcus aureus isolates from Nigeria. Afr. J. Med. Med. Sci. 24: 135-139.
14. Padilla C, Salazar M, Faundez O (1992). Range of action and genetic bacteriocin codification of Pseudomonas aeruginosa isolated from three different ecological niches, J. Appl Microbiol. 73: 497- 500.
15. Parret AHA, De Mot R (2000). Novel bacteriocins with predicted tRNase and pore-forming activities in Pseudomonas aeruginosa PAO1. Mol Microbiol. 35: 472-473.
16. Parret AHA , De Mot R (2001). Bacteriocin production by rhizospheres colonizing fluorescent Pseudomonas. Medline. pp 1 -5.
17. Petrocheilou-Malliaru K, Koukoulanis N, Legakis N (1987). Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa. Chemoterapia. 6 (2 Suppl):199.
18. Pollack M (1994). Pseudomonas aeruginosa. In:. Mandell GL, Bennett JE, Dolin R (ed), principles and practice of Infectious Diseases,4th ed. Churchill Livingstone, Inc. New York. USA. pp.1980 -2003.
19. Rogers (1973). Pyocyanins extraction in minimal media. J Bacteriol. 72: 1365-1367
20. Ryder MH, McClure NC (1997). Antibiosis in relation to other mechanisms in biocontrol by rhizobacteria. Proceedings of the Fourth International Workshop on Plant Growth Promoting Rhizobacteria. Sapporo, Japan. pp. 65 - 72.
21. Sano Y (1993). The inherent DNase of pyocin AP41 causes breakdown of chromosomal DNA. J. Bacteriol. 175: 912 - 915.
22. Sano Y, Matsui H, Kobayashi M, Kageyama M (1993). Molecular structures and functions of pyocins S1 and S2 in Pseudomonas aeruginosa. J. Bacteriol. 175:2907-2916.
23. VanLoon LC, Bakker PAHM, Pieterse CMJ (1998). Systemic resistance induced in rhizospheres bacteria. Annu. Rev. Phytopathol. 36: 453-483.
24. Weyant RS, Moss CW, Weaver RE, Frollis DG, Jordan JG, Cook EC, Daneshvar MI (1995). Identification of unusual pathogenic gram-negative aerobic and anaerobic bacteria. The Williams and Wilkins Company. Baltimore, USA. pp. 318 - 341
25. Wood, DE and Iglewski, BH (1983). Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis. Suppl. 5: S715.